Clinical Trials Browser

Phase 2 × Urinary Bladder Neoplasms × cemiplimab × Clear all

Urinary Bladder Neoplasms

NCT06571708 2025-09-02

NeoSTOP-IT

Phase 2 Recruiting

36 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT05429866 2023-03-08

Immunological Variables Associated to ICI Toxicity in Cancer Patients

Phase 2 Unknown

441 enrolled

BreastDermatologicGastrointestinalGenitourinaryHead & NeckOther solid neoplasmThoracic

Mesothelioma, Malignant, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Carcinoma, Hepatocellular, Melanoma, Carcinoma, Merkel Cell, Small Cell Lung Carcinoma

Clinical Trials

A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer

NeoSTOP-IT

Immunological Variables Associated to ICI Toxicity in Cancer Patients